E-LIB Suche - Ergebnisse für: Short, Nicholas

1

Influence of co-mutational patterns in disease phenotype an..:

Montalban-Bravo, Guillermo ; Rodriguez-Sevilla, Juan Jose ; Swanson, David Michael...
Leukemia. 38 (2024) 5 - p. 1178-1181 , 2024

Link: https://doi.org/10.1038/..

2

Outcome of 3q26.2/MECOM rearrangements in chronic myeloid l..:

Akiyama, Hiroki ; Kantarjian, Hagop ; Jabbour, Elias...
International Journal of Hematology. , 2024

Link: https://doi.org/10.1007/..

3

NPM1‐mutated myeloid neoplasms are a unique entity not defi..:

Gener‐Ricos, Georgina ; Bataller, Alex ; Rodriguez‐Sevilla, Juan Jose...
Cancer. , 2024

Link: https://doi.org/10.1002/..

4

Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resis..:

Modak, Rucha V. ; de Oliveira Rebola, Katia G. ; McClatchy, John...
Clinical Cancer Research. 30 (2024) 10 - p. 2245-2259 , 2024

Link: https://doi.org/10.1158/..

5

Prognostic risk signature in patients with acute myeloid le..:

Bataller, Alex ; Bazinet, Alexandre ; DiNardo, Courtney D....
Blood Advances. 8 (2024) 4 - p. 927-935 , 2024

Link: https://doi.org/10.1182/..

6

Outcome of Patients With Relapsed Acute Promyelocytic Leuke..:

Sasaki, Koji ; Ravandi, Farhad ; Kadia, Tapan...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. 375-381 , 2024

Link: https://doi.org/10.1016/..

7

Exploring the landscape of somatic ASXL2 mutations in myelo..:

Abuasab, Tareq ; Borthakur, Gautam ; Kanagal‐Shamanna, Rashmi...
American Journal of Hematology. 99 (2024) 7 - p. 1434-1436 , 2024

Link: https://doi.org/10.1002/..

8

Outcomes and genetic dynamics of acute myeloid leukemia at ..:

Bataller, Alex ; Kantarjian, Hagop ; Bazinet, Alexandre...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

9

Inotuzumab ozogamicin for the treatment of adult acute lymp..:

Short, Nicholas J. ; Jabbour, Elias ; Jain, Nitin.
Journal of Hematology & Oncology. 17 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

10

Azacitidine Post-transplant Maintenance Improves Disease Pr..:

Pasvolsky, Oren ; Saliba, Rima M. ; Popat, Uday R....
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

11

Phase 1 study of azacitidine in combination with quizartini..:

Montalban-Bravo, Guillermo ; Jabbour, Elias ; Chien, Kelly...
Leukemia Research. 142 (2024) - p. 107518 , 2024

Link: https://doi.org/10.1016/..

12

Cost Effectiveness of Zanubrutinib Versus Ibrutinib in Rela..:

Kang, Dong-Won ; Wang, Li ; Short, Nicholas J....
PharmacoEconomics. 42 (2024) 4 - p. 409-418 , 2024

Link: https://doi.org/10.1007/..

13

Targetable genetic abnormalities in patients with acute mye..:

Bataller, Alex ; DiNardo, Courtney D. ; Bazinet, Alexandre...
American Journal of Hematology. 99 (2024) 4 - p. 792-796 , 2024

Link: https://doi.org/10.1002/..

14

SOHO State of the Art Updates and Next Questions | Novel Ag..:

Jen, Wei-Ying ; Jabbour, Elias ; Kantarjian, Hagop M..
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

15

Oral decitabine plus cedazuridine and venetoclax in patient..:

Bataller, Alex ; Montalban-Bravo, Guillermo ; Bazinet, Alexandre...
The Lancet Haematology. 11 (2024) 3 - p. e186-e195 , 2024

Link: https://doi.org/10.1016/..